Heptagon Driehaus US Micro Cap Eq I$ Acc |
Performance History | 31/03/2024 |
Growth of 1,000 (EUR) |
Fund | 69.8 | 33.3 | -28.9 | 8.4 | 17.2 | |
+/-Cat | 52.9 | 6.6 | -11.5 | -4.7 | 8.3 | |
+/-Idx | - | 8.4 | -14.6 | -6.4 | 9.9 | |
Category: US Small-Cap Equity | ||||||
Benchmarks: Morningstar US Sml Ext NR USD |
Key Stats | ||
NAV 24/04/2024 | USD 285.00 | |
Day Change | -0.70% | |
Morningstar Category™ | US Small-Cap Equity | |
ISIN | IE00BDB53Y90 | |
Fund Size (Mil) 24/04/2024 | USD 794.59 | |
Share Class Size (Mil) 24/04/2024 | USD 113.79 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/01/2024 | 1.40% |
Investment Objective: Heptagon Driehaus US Micro Cap Eq I$ Acc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Inception Date 08/09/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell Micro Cap Growth TR USD | Morningstar US Sml Ext NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Heptagon Driehaus US Micro Cap Eq I$ Acc | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Modine Manufacturing Co | Consumer Cyclical | 3.10 |
Crinetics Pharmaceuticals Inc | Healthcare | 2.70 |
FTAI Aviation Ltd | Industrials | 2.45 |
Camtek Ltd | Technology | 2.39 |
Xenon Pharmaceuticals Inc | Healthcare | 2.19 |
Increase Decrease New since last portfolio | ||
Heptagon Driehaus US Micro Cap Eq I$ Acc |